Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
17.04
-0.06 (-0.35%)
May 8, 2025, 4:00 PM EDT - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $928.56 million as of May 8, 2025. Its market cap has decreased by -17.33% in one year.
Market Cap
928.56M
Enterprise Value
638.82M
1-Year Change
-17.33%
Ranking
Category
Stock Price
$17.04
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $928.56M, an increase of 45.82%. That is a compound annual growth rate of 9.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 931.83M | -10.37% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.79B |
| Johnson & Johnson | 376.07B |
| UnitedHealth Group | 354.59B |
| AbbVie | 329.40B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 235.12B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |